Aeolus Pharmaceuticals, Inc. (AOLS)

Aeolus Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012
Net Income	-4.09	-3.56	-2.63	-0.08	-3.21	1.7
Depreciation & Amortization	-	-	-	-	0.01	0.01
Other Amortization	0.01	0.29	-	-	-	-
Stock-Based Compensation	0.12	0.14	0.18	0.64	0.86	0.57
Other Operating Activities	-0.01	-	0	-	0.51	-4.07
Change in Accounts Receivable	0.43	0.84	-0.03	-1.19	0.41	0.9
Change in Accounts Payable	-0.07	-0.63	0.05	0.97	-1.59	0.02
Change in Unearned Revenue	-0.03	-0.02	-0.42	-0.24	0.58	0.11
Change in Other Net Operating Assets	0.3	-0.16	0.41	0.22	-0.54	-0.11
Operating Cash Flow	-3.35	-3.11	-2.44	0.32	-2.97	-0.88
Short-Term Debt Issued	-	-	1	-	-	-
Total Debt Issued	-	-	1	-	-	-
Net Debt Issued (Repaid)	-	-	1	-	-	-
Issuance of Common Stock	-	2.01	0.02	0.33	3.62	0.66
Other Financing Activities	-0.34	-0.34	-	-	-0.06	-0.02
Financing Cash Flow	-	6.17	1.02	0.33	3.56	0.64
Net Cash Flow	-3.35	3.06	-1.42	0.65	0.59	-0.24
Free Cash Flow	-3.35	-3.11	-2.44	0.32	-2.97	-0.88
Free Cash Flow Margin	-434.89%	-149.76%	-78.53%	3.35%	-75.61%	-12.05%
Free Cash Flow Per Share	-0.02	-0.02	-0.02	0.00	-0.03	-0.01
Levered Free Cash Flow	-1.81	-1.77	-1.46	0.35	-1.95	0.02
Unlevered Free Cash Flow	-1.82	-1.88	-1.46	0.35	-1.95	0.02
Change in Net Working Capital	-0.63	-0.02	-0.01	0.23	1.13	-0.93

Source: S&P Global Market Intelligence. Standard template. Financial Sources.